NEOSTIGMINE METHYLSULFATE INJECTION USP

marcan pharmaceuticals inc🇨🇦 Health Canada

Approval Id: 3c510294eb222c09
Drug Approval Canada Name: NEOSTIGMINE METHYLSULFATE INJECTION USP
Product Name: NEOSTIGMINE METHYLSULFATE INJECTION USP
Status: Marketed
Status Date: 2019-03-26
Original Market Date: 2019-03-26
Din: 02475499
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous , Intramuscular , Intravenous
Schedule: Prescription
Ahfs: 12:04.00
Atc Original: N07AA01 NEOSTIGMINE
Atc Name: n 07 aa 01
Aig Number: 0102263003
Company Name: marcan pharmaceuticals inc
Company Address: 2 Gurdwara Rd., Suite 112, Ottawa, Ontario, Canada, K2E 1A2

NEOSTIGMINE METHYLSULFATE

1 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

3c510294eb222c09

Type

Standard